Kumamoto, Japan

Shuzoh Oyama

This inventor holds 1 USPTO granted patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuzoh Oyama. Retrieved from https://idiyas.com/inventor/shuzoh-oyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuzoh Oyama: Innovator in Gammaglobulin Purification

Introduction

Shuzoh Oyama is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the purification of gammaglobulin derivatives. His innovative work has implications for both medical and industrial applications.

Latest Patents

Oyama holds a patent for the "Purification of gammaglobulin derivative." This process involves the production of a highly purified S-sulfonated gammaglobulin. The method entails treating an S-sulfonated gammaglobulin obtained by sulfonating a conventional gammaglobulin with an ion exchanger in a buffer solution. This technique allows for the absorption of single molecular S-sulfonated gammaglobulin and its subsequent elution with a buffer solution. The result is a product with a high content of single molecules and minimal anticomplementary activity, achieving a CH.sub.50 of 10% or less, along with excellent shaking stability.

Career Highlights

Shuzoh Oyama is affiliated with the Chemo-Sero-Therapeutic Research Institute, where he continues to advance his research. His work has been pivotal in enhancing the quality and stability of gammaglobulin products, which are essential in various therapeutic applications.

Collaborations

Oyama has collaborated with notable colleagues, including Akinobu Funatsu and Komei Ohashi. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Shuzoh Oyama's innovative approach to gammaglobulin purification exemplifies the impact of dedicated research in biochemistry. His contributions continue to influence the field and improve therapeutic processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…